Cargando…
PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
Abnormal angiogenesis occurs during the growth of solid tumors resulting in increased vascular permeability to fluids and metastatic cancer cells. Anti-angiogenesis therapy for solid tumors is effective in the treatment of cancer patients. However, the efficacy of anti-angiogenesis therapy is limite...
Autores principales: | Zhang, Xin, Wang, Kexin, Feng, Xingbo, Wang, Jian, Chu, Yali, Jia, Chunmeng, He, Qingsi, Chen, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578369/ https://www.ncbi.nlm.nih.gov/pubmed/34753906 http://dx.doi.org/10.1038/s41419-021-04352-w |
Ejemplares similares
-
PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis
por: Li, Zhongwei, et al.
Publicado: (2021) -
MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein
por: Zhang, Heng, et al.
Publicado: (2016) -
OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
por: Liu, Yue, et al.
Publicado: (2022) -
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
por: Yin, Shasha, et al.
Publicado: (2021) -
Regulation of HIF-1α stability by lysine methylation
por: Baek, Sung Hee, et al.
Publicado: (2016)